Using Technical Analysis, we analyzed UnitedHealth Group Inc. (UNH) stock and predicted where price would go within the next few days to weeks.
1 extracted signal · 1 resolved · 0 still active
IC Trades16 Oct 2025, 05:13 UTC
AI-generated source summary
The analysis of UNH stock begins with a review of its performance, noting the stock closed at $361.15. It identifies a gap fill zone around $375. The weekly chart reveals a previous trading range between $533 and $432 before a decline. After hitting a low of $233, there's bullish price action, including a gap up. On the daily chart, the analysis points to a previous consolidation area between $281 and $326, with buyers and sellers battling. Currently, it shows a pennant forming with a potential squeeze upwards. A retest of $375 is anticipated if it uses that as support. Resistance is noted with two recent red candles, emphasizing the potential for upside movement.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from IC Trades
IREN's Breakout Surge Triggered? | IREN Stock Analysis
APLD's (Applied Digital) Bounce Move Nearby? | APLD Stock Analysis
ONDS Ready For a Major BREAKOUT Movement? | ONDS Stock Analysis
NIO's Next BIG Move? | NIO Stock Analysis
SOFI Huge Earnings Breakout Ahead? | SOFI Stock Analysis
SMCI Massive Revival Breakout? | SMCI Stock Analysis
IC Trades
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
